Publikationen in Zusammenarbeit mit Forschern von New York University School of Medicine (10)

2024

  1. Prevalence and Trajectories of Post-COVID-19 Neurological Manifestations: A Systematic Review and Meta-Analysis

    Neuroepidemiology, Vol. 58, Núm. 2, pp. 120-133

2023

  1. Consensus Clinical Guidance for Diagnosis and Management of Adult COVID-19 Encephalopathy Patients

    Journal of Neuropsychiatry and Clinical Neurosciences, Vol. 35, Núm. 1, pp. 12-27

  2. Corrigendum to “Global uncertainty in the diagnosis of neurological complications of SARS-CoV-2 infection by both neurologists and non-neurologists: An international inter-observer variability study” [Journal of the Neurological Sciences. 2023 Jun 15;449:120646] (Journal of the Neurological Sciences (2023) 449, (S0022510X23001065), (10.1016/j.jns.2023.120646))

    Journal of the Neurological Sciences

  3. Evaluation and treatment approaches for neurological post-acute sequelae of COVID-19: A consensus statement and scoping review from the global COVID-19 neuro research coalition

    Journal of the Neurological Sciences, Vol. 454

  4. Global uncertainty in the diagnosis of neurological complications of SARS-CoV-2 infection by both neurologists and non-neurologists: An international inter-observer variability study

    Journal of the Neurological Sciences, Vol. 449

  5. Headache Triggered by Coronavirus Disease 2019 Vaccination Increases in Line with History of Allergic Disorders and Comorbidities Like Depression and Fibromyalgia: An Analysis of the US Vaccine Adverse Event Reporting System

    Neurological Sciences and Neurophysiology, Vol. 40, Núm. 4, pp. 207-214

2022

  1. Acute and post-acute neurological manifestations of COVID-19: present findings, critical appraisal, and future directions

    Journal of Neurology, Vol. 269, Núm. 5, pp. 2265-2274

  2. Changes in cognitive functioning after COVID-19: A systematic review and meta-analysis

    Alzheimer's and Dementia, Vol. 18, Núm. 5, pp. 1047-1066

  3. Neurological Events Reported after COVID-19 Vaccines: An Analysis of Vaccine Adverse Event Reporting System

    Annals of Neurology, Vol. 91, Núm. 6, pp. 756-771

  4. Timing of headache after COVID-19 vaccines and its association with cerebrovascular events: An analysis of 41,700 VAERS reports

    Cephalalgia, Vol. 42, Núm. 11-12, pp. 1207-1217